Dr. John Campbell

Excellent discussion with Russell Brand. Russell demonstrates a sound grasp of the reality of numerous situations and asks perceptive and challenging questions. Direct link to original video introduction on Stay Free Media on YouTube, https://www.youtube.com/watch?v=xh5WqeE3H-A&t=74s Direct link to original video on Stay Free Media on Rumble, https://rumble.com/v3bkb4w-i-no-longer-trust-authority-dr-john-campbell-on-moderna-myocarditis-and-mrn.html

Senate Health, Labor, and Pensions Committee hearing https://www.c-span.org/video/?c5063184/senator-paul-questions-moderna-ceo-covid-19-vaccine-side-effects Senator Rand Paul Moderna CEO Stéphane Bancel, Moderna paid NIH $400,000,000 Making money from the vaccine while dictating government policy on how many times the vaccine is used. ‘Thank you for the question Senator’ 16 to 24 years vaccine increased myocarditis, Especially after the 2nd dose "I spoke with your president just last week and he readily acknowledged, in private, that yes there is an increased risk of myocarditis. The fact that you can't say it in public is quite disturbing." CDC Covid, vaccine, myocarditis, vaccine, vaccine CDC/FDA latest guidelines https://twitter.com/FDAHealthEquity/status/1689313362717417472

USA deaths, 2020 – 2021 Years mostly complete https://www.soa.org/4a55a7/globalassets/assets/files/resources/research-report/2022/excess-death-us.pdf https://www.soa.org/49b504/globalassets/assets/files/resources/experience-studies/2022/group-life-covid-19-mortality-12-2022.pdf Deaths reported by the U.S. Centers for Disease Control and Prevention Actual-to-expected ratios (A/E ratios) using 2015-2019 April to December 2020 A/E of 122% Full year of 2020, 116.4% 13.3% excess due to COVID, and 3.1% not COVID Full year of 2021 Completed at 117% In both years, the age group with the highest A/E was ages 35-64 During 2021, excess deaths were higher in all age groupings 15 to 34 years, non-covid deaths were 21.4% higher Date through to March 2022 Excess deaths,(all ages) 115.2% excluding covid October – December 2022 35 to 44 years, 34% excess deaths Non covid deaths If the main issue was lack of access to health care, why are excess deaths highest in 15 to 34 years? Followed by 35 to 64 years? 2022 Cause of Death Report https://www.soa.org/49667f/globalassets/assets/files/resources/research-report/2022/2022-cause-death-report.pdf Cancer deaths, usually in the range of 102% to 105% of expected Cardiovascular deaths, 4% higher than expected Other non-communicable deaths, 10% lower than expected Deaths from diabetes, as high as 30% more than expected Deaths ascribed to the nervous system, sometimes as high as 30% greater than expected Respiratory deaths, in line with expected Non-Medical Deaths Deaths by suicide, (excludes drug overdoses), were noticeably lower during the pandemic Jump in death claims on insurance Higher non-covid deaths https://eu.usatoday.com/story/opinion/2023/08/11/more-americans-dying-than-before-pandemic-covid-deaths/70542423007/ NZ https://www.stats.govt.nz/topics/births-and-deaths

Senator Babet, live births https://www.youtube.com/watch?v=ezeW1JWdr9w

Second Annual Report on Medical Assistance in Dying in Canada 2020 https://www.canada.ca/en/health-canada/services/publications/health-system-services/annual-report-medical-assistance-dying-2020.html Second Annual Report on Medical Assistance in Dying Based on these regulations; https://canadagazette.gc.ca/rp-pr/p2/2018/2018-08-08/html/sor-dors166-eng.html Significant collaboration between federal, provincial and territorial levels of government, as well as practitioners and pharmacists has permitted the collection, verification and accuracy of the data contained in this report. The number of medically assisted deaths continues to increase in 2020 In 2020, there were 7,595 cases of MAID reported in Canada, accounting for 2.5% of all deaths in Canada. The number of cases of MAID in 2020 represents a growth rate of 34.2% over 2019. All provinces experienced a steady year over year growth during 2020. Total number of medically assisted deaths reported in Canada since the enactment of federal legislation in mid-2016 is 21,589 Profile of MAID recipients Men 51.9% Women 48.1% Average age, 75.3 years Cancer, 69.1% Chronic respiratory conditions, 11.3% Neurological conditions, 10.2% The majority of MAID recipients received palliative care and disability support services 88.5% were reported to have had access to these services had they wished 43.6% of MAID recipients were reported as requiring disability support services Primary care physicians remain as the principal MAID providers, but the administration of MAID has shifted to home-based settings 1,345 unique practitioners administered MAID in Canada 94.7% of providers were physicians 5.3% of providers were nurse practitioners 68.1% of cases of MAID were administered by a family physician The most commonly cited intolerable physical or psychological suffering Loss of ability to engage in meaningful activities, 84.9% Loss of ability to perform activities of daily living, 81.7% The Honourable Patty Hajdu, Minister of Health As Minister of Health, I am proud to present Health Canada's Second Annual Report on Medical Assistance in Dying (2020). Superior Court of Québec's September 2019 ruling, struck down the MAID eligibility requirement that a person's natural death must be reasonably foreseeable. Third annual report on Medical Assistance in Dying in Canada 2021 https://www.canada.ca/en/health-canada/services/publications/health-system-services/annual-report-medical-assistance-dying-2021.html 2021, 10,064 MAID provisions reported in Canada, accounting for 3.3% of all deaths in Canada. The number of cases of MAID in 2021 represents a growth rate of 32.4% over 2020. All provinces continue to experience a steady year over year growth. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01733-0/fulltext September 2022 Trudo Lemmens, health law specialist, University of Toronto “What was originally conceived as an exceptional practice in medicine has quickly become normalised” “Even before the law is set to be expanded to include mentally ill patients, we already have worryingly high numbers of people dying,” Argues that Canada's approach is far more permissive than comparator nations, including Belgium and the Netherlands. “We've failed to sufficiently safeguard against the medicalisation of ageing.” The new law enacted last year stipulates that, starting in March, 2023, MAID will be expanded to include patients with mental illnesses. First deaths expected 17th march 2024 Senator Babet, live birtha https://www.youtube.com/watch?v=ezeW1JWdr9w

A system beset by conflicts of interest MHRA approach to patient safety requires a radical overhaul encompassing legislative changes on reporting and, in a system beset by conflicts of interest, changes to how the MHRA is funded. A failure to act will only lead to more harm. CDC latest guidelines https://twitter.com/FDAHealthEquity/status/1689313362717417472 https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-immunization-schedule-ages-6months-older.pdf MPs warned Yellow Card system and vaccine damage payment scheme failing injury victims https://appgpandemic.org/news/yellow-card https://appgpandemic.org 17 July 2023 The Pandemic Response and Recovery All-Party Parliamentary Group, failings of the Yellow Card system Professor Carl Heneghan Professor of Evidence-Based Medicine at the University of Oxford, Director of the Centre for Evidence Based Medicine and an NHS General Practitioner working in urgent care. Under-reporting of adverse drug reactions to the Yellow Card system could be as high as 98%, https://yellowcard.mhra.gov.uk meaning the ability to detect signals and assign causation is substantially hindered. In theory, the Medicines and Healthcare products Regulatory Agency (MHRA) relies on the early warning system provided by Yellow Card reports of suspected adverse drug reactions (ADRs), to signal possible harms from pharmaceuticals. In practice the system is woefully inadequate, much too complicated and is failing. If you consider that ADRs are a major cause of hospital admissions, 6.5%, then Yellow Card reports represent a valuable source of information, not only to protect public health but reduce the cost to the health system, which can only be a good thing. But the ability to detect signals and assign causation are hindered by substantial problems, not least under-reporting. In 2018 the MHRA “estimated that only 10% of serious reactions and between 2 and 4% of non-serious reactions are reported” MHRA Reporting rates for covid vaccines are better due to higher public awareness, there appears to be no evidence base for this heightened awareness. Should the MHRA, our regulatory body, be primarily funded by fees derived from services to the pharmaceutical industry? We could improve the reporting system and the MHRA has published various strategies and proposals to do so but fine words butter no parsnips. The bottom line is that the MHRA has failed in its remit to keep patients safe. Peter Todd Solicitor acting for 43 who suffered blood clots as a result of AstraZeneca vaccination, VDPS https://www.gov.uk/vaccine-damage-payment is letting down those with injuries and families of those who died as a result of their injury, with some applications taking more than 18 months. “I have dealt with such cases for many years, including acting for 86 people who contracted narcolepsy due to the 2009 Pandemrix swine flu vaccine. I have noticed many parallels between that and the Covid vaccine, a hasty roll out of an under-tested emergency vaccine using new technology, and for which the government gave an indemnity against any civil claims. VDPS as of 20 June, of 6,183 applications for compensation, it has determined 2,101, 33% so far, and 139 applications have been waiting for more than 18 months, excessively long despite additional resources. Pandemic Response and Recovery APPG Co-Chair Esther McVey “What we heard has been extremely concerning. The entire system is failing patients, from start to finish. MHRA’s approach to patient safety, the inadequacy of the Yellow Card system …. are all compromised and that is severely compromising patient safety. “One serious concern is the knock on effect on people’s inclination to have vaccines generally. Many could be dissuaded from taking other vaccines, we have all seen the recent warnings of a measles outbreak in London due to low levels of vaccination. These vaccines seem to have a disproportionate adverse reaction rate, with injuries including strokes, blood clots, heart attacks, amputations and neurological conditions. So a reporting system that misses as many as 98 out of 100 adverse reactions, inevitably misses safety signals. Pandemic Response and Recovery APPG Co-Chair Graham Stringer MP I think the example of the time lag between AstraZeneca being suspended in Denmark, Norway and Iceland and being suspended here is a case in point. Why did the MHRA not act when its scientific review of UK reports of blood clots with lowered platelets concluded strong evidence of a link with AstraZeneca’s vaccine?

US and EU excess mortality persists in May 2023 Our world in data https://ourworldindata.org/grapher/excess-mortality-p-scores-average-baseline?country=~USA https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20230616-3 https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20230714-2 May 2023, excess deaths, +2.9% (8,100 excess deaths) Above the baseline period in 2016-2019) April it was +3.3% May 2022, 8% (31,100 excess deaths) May 2021, 10.7% (48,700 excess deaths) May 2020, 3.1% (9,700 excess deaths) https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/28july2023 Week ending 28 July 2023 (Week 30) 9,684 deaths registered in England and Wales 63 of these deaths mentioned novel coronavirus (COVID-19), accounting for 0.7% of all deaths. Of the 63 deaths involving COVID-19 in Week 30, 61.9% (39 deaths) had this recorded as the underlying cause of death Deaths registered in the UK Week 30 were 11,115 0.8% above the five-year average (91 excess deaths) https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9

With professor Robert Clancy. The Curious Tale of Hydroxychloroquine You have prescribed hydroxychloroquine (HCQ) 20,000 times, why do you use it and what side effects do you commonly see? Has medicine changed in the past few years, influenced by powerful commercial and political forces? Is WHO a threat to independent local health systems? The doctor-patient relationship, and science-based medicine. Why are these important? Is there a concern over conflict of interest created by grants and payments from pharmaceutical companies? Emergency Use Authorization of Medical Products and Related Authorities https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities d. No Alternatives For FDA to issue an EUA, there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition. A potential alternative product may be considered “unavailable” if there are insufficient supplies of the approved alternative to fully meet the emergency need. A potential alternative product may be considered "inadequate" if, for example, there are contraindicating data for special circumstances or populations (e.g., children, immunocompromised individuals, or individuals with a drug allergy), if a dosage form of an approved product is inappropriate for use in a special population (e.g., a tablet for individuals who cannot swallow pills), or if the agent is or may be resistant to approved and available alternative products.

Select Subcommittee on the Coronavirus Pandemic Chairman Dr. Brad Wenstrup (Ohio) https://www.youtube.com/watch?v=O_eXm9wOkS8 https://www.youtube.com/watch?v=10I3hQUf3oI&t=10s https://oversight.house.gov/subcommittee/select-subcommittee-on-the-coronavirus-pandemic/ https://www.youtube.com/watch?v=9fKWYFsupQk https://oversight.house.gov/release/wenstrup-opens-investigation-into-federal-covid-19-vaccine-mandates/ https://oversight.house.gov/release/wenstrup-to-hold-first-hearing-on-covid-origins/ Investigation into overreaching, federal COVID-19 vaccination mandates and policies at the, Department of Defense (DOD), U.S. Office of Personnel Management (OPM), Department of Labor (DOL), and Department of Health and Human Services (HHS). Chairman Wenstrup is requesting access to all documents, communications, and guidance, utilized by these agencies to craft their coercive policies prior to forcing a novel vaccine — that did not stop the spread or transmission of the virus — on millions of Americans. At the Select Subcommittee’s hearing on vaccine mandates last week, expert witnesses highlighted the Biden Administration’s abuse of executive power and disregard for individual freedoms that resulted in employment termination, decreased military readiness, and increased distrust in public health authorities. The Select Subcommittee is seeking further information from DOD, OPM, DOL, and HHS regarding any political interference by the Biden White House and other outside organizations on federal COVID-19 vaccine mandates.

Select Subcommittee on the Coronavirus Pandemic Chairman Dr. Brad Wenstrup (Ohio) https://www.youtube.com/watch?v=O_eXm9wOkS8 https://www.youtube.com/watch?v=10I3hQUf3oI&t=10s https://oversight.house.gov/subcommittee/select-subcommittee-on-the-coronavirus-pandemic/ https://www.youtube.com/watch?v=9fKWYFsupQk https://oversight.house.gov/release/wenstrup-opens-investigation-into-federal-covid-19-vaccine-mandates/ https://oversight.house.gov/release/wenstrup-to-hold-first-hearing-on-covid-origins/ Investigation into overreaching, federal COVID-19 vaccination mandates and policies at the, Department of Defense (DOD), U.S. Office of Personnel Management (OPM), Department of Labor (DOL), and Department of Health and Human Services (HHS). Chairman Wenstrup is requesting access to all documents, communications, and guidance, utilized by these agencies to craft their coercive policies prior to forcing a novel vaccine — that did not stop the spread or transmission of the virus — on millions of Americans. At the Select Subcommittee’s hearing on vaccine mandates last week, expert witnesses highlighted the Biden Administration’s abuse of executive power and disregard for individual freedoms that resulted in employment termination, decreased military readiness, and increased distrust in public health authorities. The Select Subcommittee is seeking further information from DOD, OPM, DOL, and HHS regarding any political interference by the Biden White House and other outside organizations on federal COVID-19 vaccine mandates.

Great to learn from professor Robert Clancy. Every time I learn so much. Robert is a consultant physician and pioneering immunologist, professor of medicine, emeritus professor of pathology, doctor of medicine, doctor of philosophy and doctor of science, author, teacher and broadcaster. Also holder of the Order of Australia.

Journals have devolved into information laundering operations for the pharmaceutical industry Pharmaceutical company advertising in The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61019-2/fulltext (Illustration: Margaret Shear, Public Library of Science) https://journals.plos.org/plosmedicine/article/figure?id=10.1371/journal.pmed.0020138.g001 Editor, The Lancet, Richard Horton “Journals have devolved into information laundering operations for the pharmaceutical industry.” (Published in ‘The dawn of McScience’) Former New England Journal of Medicine Editor, Marcia Angell Describing information from the pharmaceutical industry as coming, “mixed with hyperbole, bias and misinformation, and there is often no way to tell which is which.” (Published in ‘The truth about the drug companies: how they deceive us and what to do about it.’) Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020138 Journals, “primarily a marketing machine” and co-opting “every institution that might stand in its way” Some studies found that journal advertisements were more strongly associated with prescribing than the scientific articles in the same journals, others found advertising associated with less rational prescribing, and greater prescribing costs. However, none found associations between exposure to journal advertisements and improved quality of prescribing, reduced cost, or reduced prescribing overall. “the findings support the case for reforms to reduce negative influence to prescribing from pharmaceutical promotion.” Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review https://pubmed.ncbi.nlm.nih.gov/20976098/ (PLoS Medicine) Background: Pharmaceutical industry claims that promotion provides scientific and educational information to physicians. To examine the relationship between exposure to information from pharmaceutical companies to prescribing. Outcome measures: Quality, quantity, and cost. Exposures included Pharmaceutical sales representative visits Journal advertisements Attendance at pharmaceutical sponsored meetings Mailed information Prescribing software Participation in sponsored clinical trials Wide literature search, 58 included studies with 87 analyses. Five found associations between exposure to pharmaceutical company information and lower quality prescribing Five included studies found evidence for association with higher costs 38 studies, associations between exposure and higher frequency of prescribing Conclusions Studies of exposure to information provided directly by pharmaceutical companies have found associations with higher prescribing frequency, higher costs, or lower prescribing quality We did not find evidence of net improvements in prescribing We recommend that practitioners follow the precautionary principle, and thus avoid exposure to information from pharmaceutical companies. John Paul II https://www.gmwatch.org/en/news/archive/2004/7941-the-dawn-of-mcscience "overriding financial interests" operate in biomedical and pharmaceutical research. These forces prompted, "decisions and products which are contrary to truly human values and to the demands of justice." "the pre-eminence of the profit motive in conducting scientific research ultimately means that science is deprived of its epistemological character, according to which its primary goal is discovery of the truth. The risk is that when research takes a utilitarian turn, its speculative dimension, which is the inner dynamic of man's intellectual journey, will be diminished or stifled."

WHO admits excess deaths Global excess deaths associated with COVID-19, January 2020 - December 2021 https://www.who.int/data/stories/global-excess-deaths-associated-with-covid-19-january-2020-december-2021 New hope children centre https://www.newhopeuplands.org If you would like to support the work in Africa, donations are welcome using the PayPal link below. 100% of funds go directly to Africa. Thank you. https://www.paypal.com/donate/?hosted_button_id=XS59XPZ527YFL A comprehensive view of global deaths directly and indirectly associated the COVID-19 pandemic. The World Health Organization (WHO) is tracking global excess mortality as the pandemic evolves over time to reveal a picture of its full impact and burden on countries, health systems and individuals. 'Excess mortality' is defined as the difference between the total number of deaths that have occurred and the number of deaths that would have been expected in the absence of the pandemic i.e. a no-COVID-19 scenario. Understanding the excess mortality: Excess mortality includes deaths attributable directly to COVID-19, includes deaths attributable directly to COVID-19 that were not counted or reported, includes deaths indirectly associated with COVID-19, due to other causes and diseases, resulting from the wider impact of the pandemic on health systems and society. It is minus any deaths that would have occurred under normal circumstances but were averted due to pandemic-related changes in social conditions and personal behaviors, e.g. less traffic deaths or influenza deaths due to local lockdowns and less travel. No mention of Adverse effects of lockdowns, social, economic, psychological, psychiatric Adverse events of medical interventions (iatrogenesis) https://www.cbc.ca/news/canada/hamilton/covid-mcmaster-fall-booster-shots-1.6923295 https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-guidance-use-covid-19-vaccines-fall-2023.html Vaccination of individuals who are pregnant Studies continue to support vaccination during pregnancy. Safety of Omicron-containing bivalent mRNA COVID-19 vaccines The safety profile of the bivalent mRNA COVID-19 vaccine boosters is comparable to that of original mRNA COVID-19 vaccine boosters No evidence on VE against infant outcomes is available for vaccination with bivalent mRNA vaccines in persons who are pregnant. In Western Australia https://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Immunisation/Western-Australia-Vaccine-Safety-Surveillance-Annual-Report-2021.pdf Total AEFI rate following a COVID-19 vaccine was 264.1 per 100,000 doses. 26.41 per 10 thousand 2.641 per thousand 0.241% One in 414 doses Of these AEFI, (adverse events following immunisation) 10,428 (97%) occurred after a COVID-19 vaccine 21 times more common than ‘conventional’ vaccines Myocardial Injury after COVID-19 mRNA-1273 Booster Vaccination https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2978 One in 35 recipients (2.8%) had vaccine-associated myocardial injury

The truth about myocarditis and Covid vaccines: After ….. https://www.dailymail.co.uk/health/article-12339279/Covid-vaccine-myocarditis-heart-Elon-Musk-bronny-james.html Two facts — both of which are widely misinterpreted Fact One mRNA jabs can cause myocarditis, an extremely rare complication that causes inflammation of the heart muscle) Fact two That heart-related deaths are massively above levels seen pre-pandemic. Conflating the two is not only incorrect, but irresponsible. Swiss study Myocardial Injury after COVID-19 mRNA-1273 Booster Vaccination https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2978 mRNA-1273 vaccine-associated myocardial injury was adjudicated in 22 participants (2.8%). One in 35 recipients (2.8%) had vaccine-associated myocardial injury Matched controls, elevated high-sensitivity cardiac troponin T concentration Significantly higher in post vaccination group p<0.001 N = 777 per group Thai study Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414075/ After BNT162b2, 2nd dose, Thai adolescents, aged 13–18 years, n = 314 Most common cardiovascular signs and symptoms Tachycardia (7.64%) Shortness of breath (6.64%) Palpitation (4.32%) Chest pain (4.32%) Hypertension (3.99%) One participant could have more than one sign and/or symptom Cardiovascular manifestations were found in 29.24% of patients Seven participants (2.33%) exhibited at least one elevated cardiac biomarker Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis Four patients had suspected subclinical myocarditis The clinical presentation of myopericarditis after vaccination was usually mild and temporary, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for cardiovascular side effects. Israeli study A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons https://pubmed.ncbi.nlm.nih.gov/36097844/ Incidence of myocardial injury after fourth dose BNT162b2 mRNA vaccine (Pfizer-BioNTech) N = 324 High-sensitivity cardiac troponin (hs-cTn) Vaccine-related myocardial injury was defined as hs-cTn elevation above the 99th percentile upper reference limit, and >50% increase from baseline measurement. Reported vaccine-related adverse reactions Fatigue in 39 (12.04%) Myalgia in 32 (9.88%) Sore throat in 21 (6.48%) Headache in 18 (5.5%) Fever ≥38°C in 16 (4.94%) Chest pain in 12 (3.7%) Palpitations in 7 (2.16%) Shortness of breath in one (0.3%) Vaccine-related myocardial injury in two (0.62%) The two cases had mild or no symptoms and no clinical sequela. US study Autopsy Proven Fatal COVID-19 Vaccine-Induced Myocarditis https://www.preprints.org/manuscript/202307.1198/v1 All autopsy studies, vaccine-induced myocarditis as a possible cause of death Most cases had symptoms consistent with myocarditis prior to death We established that all 28 deaths were causally linked to COVID-19 vaccination by independent adjudication. Number of days from last COVID-19 vaccination until death UK government data on excess deaths https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9 Age groups and causes of death

Facebook Bowed to White House Pressure, Removed Covid Posts Internal Meta emails say pressure from Washington was behind a decision to take down posts attributing pandemic to man-made virus https://www.wsj.com/articles/facebook-bowed-to-white-house-pressure-removed-covid-posts-2df436b7 https://www.telegraph.co.uk/world-news/2023/07/28/facebook-deleted-covid-virus-manmade-posts-pressure-biden/ Email from Nick Clegg Asked why company was removing rather than labelling or demoting post about viral origins Facebook vice-president in charge of content policy “We were under pressure from the administration and others to do more,” “We shouldn’t have done it.” Jim Jordan, Republican house judiciary committee “documents begin to reveal the pressure that Facebook and other social media companies were under to alter their content moderation policies, and remove protected speech to appease the federal government, particularly the Biden White House”. First Amendment https://constitution.congress.gov/constitution/ Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the people peaceably to assemble, and to petition the Government for a redress of grievances. New hope children centre https://www.newhopeuplands.org If you would like to support the work in Africa, donations are welcome using the PayPal link below. 100% of funds go directly to Africa. Thank you. https://www.paypal.com/donate/?hosted_button_id=XS59XPZ527YFL

New hope children centre https://www.newhopeuplands.org If you would like to support the work in Africa, donations are welcome using the PayPal link below. 100% of funds go directly to Africa. Thank you. https://www.paypal.com/donate/?hosted_button_id=XS59XPZ527YFL Royal colleges in the UK Have received more than £9m in marketing payments from drug and medical devices companies since 2015 The Royal College of Physicians and the Royal College of General Practitioners, biggest recipients of industry money https://www.bmj.com/content/bmj/382/bmj.p1658.full.pdf BMJ 2023;382:p1658 http://dx.doi.org/10.1136/bmj.p1658 Published: 26 July 2023 Medical royal colleges do not always disclose publicly the millions of pounds they receive from drug and medical device companies. The BMJ asked the colleges to disclose all payments from industry …. but they all refused to do so. The colleges are not obliged to disclose these payments; they are not included in their annual reports, and are only available through voluntary industry transparency initiatives, which experts say have severe limitations. Drug companies Gave £7.5m to royal colleges in the years 2015 to 2022, (for which data were available) Royal College of Physicians, £ 2.8 million Royal College of GPs, £2.4 million The biggest donor overall was Pfizer £1.8m of payments Novo Nordisk with £730 000 Daiichi Sankyo with £478 000 Since 2012 the College of Psychiatrists of Ireland Has refused to take any sponsorship from drug companies, noting, research “overwhelmingly” shows that clinicians are influenced by industry marketing, and that this affects prescribing. Emma Hardy, All Party Parliamentary Group on Surgical Mesh Implants. “Medicine is literally a matter of life and death, and patients must be confident they are receiving the best treatment available for the right reasons.” https://www.bbc.co.uk/news/health-45604199 Up to 170,000 people who have had hernia mesh implants in England in the past six years could face complications, Margaret McCartney, GP, former Royal College of General Practitioners trustee and council member “Even if we are told the information is independent, funding skews the types of education or information that gets made,” “It means that we become less independent, because we are not setting our own priorities, and that’s bad for the profession.” Conflict of interest scandals In March 2023 the Association of the British Pharmaceutical Industry temporarily suspended the drug company Novo Nordisk, because of “serious breaches” of the association’s code of practice. (The ABPI only saves the data on payments for the most recent three years and deletes historical data) Data compiled from Disclosure UK An online database run by the Association of the British Pharmaceutical Industry (ABPI), (where drug companies disclose payments to healthcare organisations, patient groups, and health professionals, who have consented for these payments to be made public) Piotr Ozieranski, (Bath University), and Shai Mulinari, (Lund University) Payments were reported under wide categories, were changed without explanation, or were inconsistent between data sources. It is impossible to tell how much money goes to each recipient, “without many hours of forensic work,”

Myocardial Injury after COVID-19 mRNA-1273 Booster Vaccination https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2978 Department of Cardiology and Cardiovascular Research Institute Basel (ESC Heart Failure, open-access journal of the Heart Failure Association of the European Society of Cardiology) Prospective active surveillance study (Not a retrospective passive surveillance study) Industry independent, instigated by the investigators Aims Incidence and potential mechanisms of oligosymptomatic myocardial injury, following COVID-19 mRNA booster vaccination. Safety net for those already boosted, screening and prevention of complications Methods and Results December 2021 to February 2022 Hospital employees scheduled to undergo mRNA-1273 booster vaccination, assessed for mRNA-1273 vaccination-associated myocardial injury, defined as acute dynamic increase in high-sensitivity cardiac troponin T (hs-cTnT) concentration, above the sex-specific upper-limit of normal on day 3 (48-96h) after vaccination without evidence of an alternative cause. 777 participants Median age 37 years, 69.5% women 40 participants (5.1%) had elevated high-sensitivity cardiac troponin T concentration on day 3 (Taken as above the 99th percentile for age and sex) mRNA-1273 vaccine-associated myocardial injury was adjudicated in 22 participants (2.8%). One in 35 recipients (2.8%) had vaccine-associated myocardial injury Of the 777, 2 women had chest pain Of these 22 cases with mRNA-1273 vaccine-associated myocardial injury Twenty cases occurred in women Two in men Hs-cTnT-elevations were mild and only temporary. No patient had ECG- changes, none developed major adverse cardiac events within 30 days In the overall booster cohort hs-cTnT concentrations, on day 3 Median 5 ng/L, IQR, 4-6 Matched controls (n=777), 3 ng/L IQR, 3-5 Significantly higher p less than 0.001 (If elevated on day3, given warning, investigations and advice) No MACE (major adverse cardiac events) within 30 days Cases had comparable systemic reactogenicity Concentrations of cytokines and cytokine antagonists were markers quantifying systemic inflammation Lower concentrations GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) induces the development of monocytes, neutrophils, eosinophils, and myeloid and dermal dendritic cells. IFN- λ1(IL-29) a group of anti-viral cytokines, that consists of four IFN-λ molecules Conclusion mRNA-1273 vaccine-associated myocardial injury was more common than previously thought, being mild and transient, and more frequent in women versus men. The possible protective role of IFN-λ1(IL-29) and GM-CSF warrant further studies. Similar Pfizer studies A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons https://pubmed.ncbi.nlm.nih.gov/36097844/ A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2687\ NZ Pfizer add https://www.everydayheroestakeaction.co.nz/?cmp=4cb06943-ef5f-42d8-a5ec-558705280295&ttype=IN&fbclid=PAAabAcBB-HdSUGJ0ZWreXCquT1cuen2z6RbI5ja2lhiMYCDlfyTVFYqj-Ri0_aem_ASwusg7kvCVjmKH2P0IcpOhiofhq24SJ5j9olm-Nu18iz66ygOkrGjbnIu8km0HD9fA2UY50a5Fiu1h4xVVS7fbW

Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/vitamin-d-deficiency-and-insufficiency-among-us-adults-prevalence-predictors-and-clinical-implications/44E436843510FE6BDE856D5BCB9C651F (University of Michigan School of Medicine, 2018) Vitamin D deficiency (VDD) and insufficiency (VDI) are increasing at a global level Serum 25-hydroxyvitamin D (25(OH)D) measurements were collected from 26,010 adults (National Health and Nutrition Examination Survey, NHANES) VDD, less than 50 nmol/l (20 ng ml) VDI, 50 to 75 nmol/l (20 – 25 ng ml) Prevalence VDD, 28·9% VDI, 41·4 % Adults who were black, less educated, poor, obese, physically inactive and infrequent milk consumers Obese adults, 3·09 times higher prevalence of VDD (1·80 times higher prevalence of VDI) Physically inactive adults, 2·00 times VDD (1·36 times higher prevalence of VDI) Vitamin D status in the United States, 2011–2014 https://academic.oup.com/ajcn/article/110/1/150/5487983?login=false Persons with higher vitamin D dietary intake or who used supplements had lower prevalences of at risk of deficiency or inadequacy. Vitamin D deficiency 2.0: an update on the current status worldwide https://www.nature.com/articles/s41430-020-0558-y Most studies did not meet the basic requirements of a nutrient intervention study ~40% of Europeans are vitamin D deficient, and 13% are severely deficient Vitamin D deficiency (serum 25-hydroxyvitamin D less than 50 nmol/L or 20 ng/ml), associated with unfavourable skeletal outcomes, including fractures and bone loss Level of more than 50 nmol/L or 20 ng/ml is, therefore, the primary treatment goal Severe vitamin D deficiency, below less than 30 nmol/L (or 12 ng/ml), dramatically increases the risk of excess mortality, infections, and many other diseases, and should be avoided whenever possible. Given its rare side effects and its relatively wide safety margin, it may be an important, inexpensive, and safe adjuvant therapy for many diseases, but future large and well-designed studies should evaluate this further. Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/dad2.12404 Vitamin D exposure was associated with 40% lower dementia incidence versus no exposure. (Prospective, n = 12,388) Low vitamin D serum levels as risk factor of Alzheimer’s disease: a systematic review and meta-analysis https://ejnpn.springeropen.com/articles/10.1186/s41983-023-00676-w Serum vitamin D levels, related to cognitive dysfunctions, e.g. dementia, including Alzheimer’s disease Past studies vary in results on whether vitamin D levels correlated with the development of AD. Meta-analysis, up to December 2022 AD, 75% of dementias Results 6 studies, n = 10,884 Vitamin D receptors throughout the brain Patients, vitamin D serum levels (less than 25 ng/ml), had an increased risk of developing AD, compared to more than 25 ng/ml HR: 1.59 Severe deficiency (less than 10 ng/ml) having the strongest association, compared to moderate vitamin D deficiency (10–20 ng/ml). Vitamin D may promote the clearing of amyloid plaques Vitamin D also prevents cognitive dysfunction via neuroprotection, neurotrophy, neurotransmission, and neuroplasticity Potential to prevent neuroinflammation, inhibits proinflammatory cytokines https://www.gov.uk/government/publications/vitamin-d-for-vulnerable-groups/vitamin-d-and-clinically-extremely-vulnerable-cev-guidance In the UK during autumn and winter, everyone is advised to take a supplement containing, 10 micrograms (400 international units) of vitamin D a day https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

Similar pattern of excess deaths in many countries around the world ONS, UK, week ending 7 July 2023 (Week 27), https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/7july2023 Deaths registered in the UK, 11,147, (2.9% above) https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9

Yes, and how many times can a man turn his head And pretend that he just doesn’t see (Bob Dylan) Autopsy Proven Fatal COVID-19 Vaccine-Induced Myocarditis https://www.preprints.org/manuscript/202307.1198/v1 COVID-19 vaccines have been linked to myocarditis which in some circumstances can be fatal. This systematic review aims to investigate potential causal links between COVID-19 vaccines and death from myocarditis using post-mortem analysis. A systematic review of all published autopsy reports involving COVID-19 vaccination-related myocarditis Through July 3rd, 2023. All autopsy studies that include COVID-19 vaccine-induced myocarditis as a possible cause of death were included Causality in each case Determined by three independent reviewers with cardiac pathology experience and expertise. Results Initially identified 1,691 studies After screening, 14 papers, 28 autopsy cases. (The cardiovascular system was the only organ system affected in 26 cases) In 2 cases, myocarditis a consequence from multisystem inflammatory syndrome (MIS). Number of days from last COVID-19 vaccination until death We established that all 28 deaths were causally linked to COVID-19 vaccination by independent adjudication. Conclusions Temporal relationship, internal and external consistency Deceased, with known COVID-19 vaccine-induced myocarditis Pathobiological mechanisms Related excess death Complemented with autopsy confirmation Independent adjudication Application of the Bradford Hill criteria Overall epidemiology of vaccine myocarditis suggests there is a high likelihood of a causal link between COVID-19 vaccines and death from suspected myocarditis, in cases where sudden, unexpected death has occurred in a vaccinated person. Urgent investigation is required for the purpose of risk stratification, and mitigation, in order to reduce the population occurrence of fatal COVID-19 vaccine-induced myocarditis. More information Most cases had symptoms consistent with myocarditis prior to death, (chest pain, effort intolerance) Choi et al, a 22-year-old Korean man Autopsy showed intense inflammation and destruction of cardiac tissue including the conduction system. Other cases had no reported symptoms before death. Gill et al reported two boys, age 16 and 17, who died a few days after mRNA injection while asleep at home. Autopsies revealed patchy inflammation suggesting that sudden arrhythmic death had occurred.

New hope children centre https://www.newhopeuplands.org If you would like to support the work in Africa, donations are welcome using the PayPal link below. 100% of funds go directly to Africa. Thank you. https://www.paypal.com/donate/?hosted_button_id=XS59XPZ527YFL It is generally acknowledged that adverse events are under-reported around the world, https://www.tga.gov.au/news/media-releases/new-web-service-helps-consumer-reporting-side-effects?fbclid=IwAR3CWUsyEoZ54fzXE1TIEqhUAZjynzMeEjRf2w_8W-jASWmLnwj1_7odSFM with estimates that 90-95% of adverse events are not reported to regulators. In recent years evidence has emerged that adverse event reports from consumers contain information that is useful for monitoring the safety of therapeutic products, but there is low awareness of available reporting systems. In Western Australia https://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Immunisation/Western-Australia-Vaccine-Safety-Surveillance-Annual-Report-2021.pdf Total AEFI rate following a COVID-19 vaccine was 264.1 per 100,000 doses. 26.41 per 10 thousand 2.641 per thousand 0.241% How to report in Australia https://aems.tga.gov.au https://aems.tga.gov.au/privacy/ https://aems.tga.gov.au/report-unregistered/?id=2da2d6a9-0d26-ee11-8172-005056a9ce6f How to report in UK https://yellowcard.mhra.gov.uk How to report in the US https://vaers.hhs.gov/reportevent.html https://vaers.hhs.gov/esub/index.jsp Yellow Card: Yellow card scheme, Don’t wait for someone else to report it https://www.gov.uk/drug-safety-update/yellow-card-please-help-to-reverse-the-decline-in-reporting-of-suspected-adverse-drug-reactions It is estimated that only 10% of serious reactions and between 2 and 4% of non-serious reactions are reported. Under-Reporting of Adverse Drug Reactions https://link.springer.com/article/10.2165/00002018-200629050-00003 12 countries, 43 numerical estimates of under-reporting. The median under-reporting rate across the 37 studies was 94% In primary care Non serious, 95% under reported Serious or severe, 80% under reported Hospital based More severe or serious, 85% to 95% under reported As an Australian I feel utterly let down. Grateful for WA for making this report available, but it leaves such a bad taste in the mouth to know how we were lied to. I did not want the vaccine and felt pushed from all sides to get it. As a West Australian I can say that doctors were discouraged to report adverse events and were reprimanded if they reported too many. The red flag system in Australia took about 45mins to report and doctors were not paid to do so. This data is absolutely doctored and controlled. I fled WA to another State with my family as soon as the unvaccinated could travel outside of the State domestically. I work in the medical field and lived in a suburb surrounded by the medical profession. The GPs who weren't afraid to report these events started getting phone calls from the Department of Health questioning their opinions and asking them to retract their reports and registrars/junior doctors working in hospitals were told to remove vaccine injury from patient notes by senior staff. My mother was vaccine injured and did not report it to the VAERS system. I imagine others like her are part of why the US has poor data on vaccine side effects. I live in Alberta, Canada. I worked for a group of general practitioners during the height of covid and the vaccine implementation. I can tell you first hand that the physicians I worked for purposefully did NOT report vaccine side effects regardless of their legal obligation to due so. When I inquired about it, it was strongly implied that I mind my own business. Interesting. I am in BC and know my reported side affects were not reported as asked later and was told could not tell me and did not know who to direct me to.

Senator Gerard Rennick (Queensland) in an open discussion about excess deaths and vaccine related issues in Australia. Western Australian Vaccine Safety Surveillance – Annual Report 2021 https://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Immunisation/Western-Australia-Vaccine-Safety-Surveillance-Annual-Report-2021.pdf Western Australia had implemented a stringent lockdown of borders and there were virtually NO cases of Covid-19 in Western Australia during 2021. The vaccine role out began February 2021. So that demonstrates the adverse reactions resulted directly from the Covid-19 vaccines and NOT the Covid-19 virus. Is there something here for the rest of Australia and indeed the world to learn from? Of all the adverse events following immunisation that took place in the WA population, what percentage would you estimate were actually reported to the Western Australian Vaccine Safety Surveillance (WAVSS)? What do you think the culture was in the health care services during the vaccine role out, was it to encourage reporting of potential adverse events or was the culture to discourage reporting to WAVSS? In WA in 2020, 2,071,167 doses of pre-covid (traditional) vaccines were given to the population as a whole, this resulted in 270 reports of adverse events following immunisation. For the 3,948,673 COVID-19 vaccines given in 2021, there were 10,726 individual AEFI reports in 2021. (97% of these reports followed covid vaccination) What do you think this tells us about the frequency of adverse events following covid vaccines in comparison to traditional vaccines? This is a horrendous volume of adverse events following immunisation. Do you feel the rate of adverse events would be equally high throughout the rest of Australia? (or was WA a ‘special case’) Total reported AEFI rate following a COVID-19 vaccine was 264.1 per 100,000 doses. For non-covid (traditional) vaccinations in WA, during the same 2021-time frame there were 11.1 events per 100,000 doses. Why did we had to waite until July 2023 to get this data? Should this have been seen as a ‘red flag’ by the regulators contemporaneously in 2021? If so, what should they have done about the problem? Some of the important AEFI that have been specifically monitored by the TGA-coordinated national surveillance vaccine safety program include, Anaphylaxis, Thrombosis with thrombocytopaenia syndrome (TTS), Immune thrombocytopenic purpura (ITP), Guillain-Barré syndrome (GBS), Myocarditis, Pericarditis, Myopericarditis, Chest pain, Deep venous thrombosis, Pulmonary embolism and Bell’s palsy, to name but a few. Given that we know all of this now, how should this effect the regulatory approval of the current mRNA vaccines? In 2021 there were 1,125 appointments made at the adult vaccine safety clinic at Sir Charles Gairdner Hospital, up from seven appointments made in 2020. Do you consider this level of referrals indicated the vaccines were safe? In 2021 there were 439 appointments made at the Perth Children’s Hospital specialist immunisation clinic, up from 214 in 2020. Does this have any implications for vaccinating children with covid vaccines?

ONS excess deaths data https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/30june2023 Week ending 30 June 2023 (Week 26) 10,373 deaths were registered in England and Wales 129 of these deaths mentioned novel coronavirus (COVID-19), accounting for 1.2% of all deaths. Of the 129 deaths involving COVID-19 61.2% (79 deaths) had this recorded as the underlying cause of death Number of deaths was above the five-year average Private homes, 22.9% above, (589 excess deaths) Hospitals, 6.1% above, (257 excess deaths) Care homes, 3.7% above, (70 excess deaths) The number of deaths registered in the UK in the week 11,763 8.8% above the five-year average (950 excess deaths) European excess deaths https://ec.europa.eu/eurostat/cache/recovery-dashboard/ https://ec.europa.eu/eurostat/statistics-explained/index.php?oldid=509982#Excess_mortality_in_the_EU_between_January_2020_and_May_2023 Excess mortality in the EU between January 2020 and May 2023 Followed the covid waves in 2020 and 2021 Following based on 2016-2019 EU data, 2022 January, + 8.1% February, + 8.3% March, + 6.7% April, + 12% May, + 8% June, + 8.4% July, + 17.1% 58, 000 additional deaths in the EU in July 2022 (2.8 % in July 2020, 11 500 excess deaths) (5.7 % in July 2021, 19 700 excess deaths) Auguste, + 13.9% (7.6 % in August 2020, 27 300 excess deaths) (9.1 % in August 2021, 36 000 excess deaths) September, + 10.3 % October, + 11.6% November, + 8.7% December, + 20.0 % 92, 500 additional deaths in December 2022 in the EU January-March, 2023 January, + 3.9 % February, -1.4 % March, + 0.9 % April, + 3.3 % (11, 900 additional deaths) May, + 2.9 % (8, 100 additional deaths) January 2020 to May 2023 1, 765, 000 additional deaths (compared with the average number for the same period in 2016-2019) 2020, 11.8 % higher 2021, 14.0 % higher 2022, 11.1 % higher First five months of 2023, 1.9 % higher In 2022 Romania (3.4 %) Sweden (3.9 %) Hungary (5.2 %) Cyprus (26.4 %) Malta (17.9 %) Finland (17.1 %) In the first five months of 2023 Bulgaria (-9.3 %) Romania (-9.0 %) Lithuania (-8.5 %) Ireland (10.2 %) Netherlands (9.5 %) Austria (9.3 %) Vaccine safety: content alleging that vaccines cause chronic side effects, outside of rare side effects that are recognized by health authorities https://support.google.com/youtube/answer/11161123?sjid=13083388330982415003-EU https://support.google.com/youtube/answer/9891785?sjid=13083388330982415003-EU Claims about COVID-19 vaccinations that contradict expert consensus from local health authorities or WHO Claims that an approved COVID-19 vaccine will cause death, infertility, miscarriage, autism, or contraction of other infectious diseases Claims that COVID-19 vaccines will make people who receive them magnetic